Claude designs binders against five scorpion neurotoxins
In a mostly autonomous 64-hour campaign, Claude designed minibinders against five neurotoxins. External labs tested 211 designs, 17 of which met the criteria; the best (Cn2-B1 and Cn2-B2) had affinities in the low nanomolar range. Only recombinant toxins were tested, with no neutralization tests in cells or animals; Anthropic does not claim to have produced an antivenom.
Technology: Claude
Family Claude: profile · models page
Publication: Announcement only · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Announcement only
- Test type: direct test
- Tested: External labs tested 211 designs by surface plasmon resonance: Adaptyv Bio in cell-free expression and Twist Bioscience in human kidney cells; a binder needed KD of 1 µM or tighter in every replicate at both labs and no CLEC12A signal, giving 17 binders. The two collaborating external laboratories tested candidates from the discovery project; this establishes direct testing rather than a separately established independent follow-up replication.
- Still unknown: Only recombinant toxins were tested, with no neutralization in cells or animals; the authors do not know whether the binders neutralize venom and do not claim an antivenom; multitoxin designs failed.
- AI role: Claude selected toxin structures and hotspots, generated 318,484 designs, filtered and co-folded them, ran about 24 hours autonomously, then produced 180 selected designs after human follow-ups.
Evidence sources: https://www.anthropic.com/research/claude-scorpion-toxin-binder-design
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: blog. Paper: not linked in this catalog; this does not mean no paper exists.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.